Skip to main content

List Alan's Form 4 filing

Precision Biosciences Inc (DTIL) · filed Apr 28, 2022

Accession no.
0001209191-22-026041
Filed
Apr 28, 2022
Trade date
Apr 26-27, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $16.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
List AlanCIK 0001858530Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 26, 2022Common StockMOption exerciseAcquired+26,035–F2–26,035Direct
Apr 27, 2022Common StockSSaleDisposed−7,775$2.10−$16,327.518,260Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 26, 2022Common StockMOption exerciseDisposed−26,035$0.00$052,055Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Each RSU represents a contingent right to receive one share of the Company's Common Stock.

Referenced by the price of 1 transaction in Table I.

Remarks

Exhibit List: Exhibit 24 Power of Attorney

Read the full filing on SEC EDGAR (opens in a new tab)